Your session is about to expire
← Back to Search
Exercise Program for Cancer Survivors (EXCEL Trial)
N/A
Recruiting
Led By Nicole Culos-Reed, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age over 18 years
About to have treatment, currently having treatment, or have had cancer treatment within the last 5 years
Must not have
Unable to participate in exercise
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to one-year
Awards & highlights
No Placebo-Only Group
Summary
This trial will provide cancer survivors in rural and remote areas with tailored exercise programs to help them manage their cancer and encourage them to become life-long exercisers.
Who is the study for?
This trial is for adults over 18 who are about to start, currently undergoing, or have completed cancer treatment within the last 5 years. Participants must be able to read/write in English and access online programs if needed. They should be capable of mild physical activity and have a diagnosis of cancer.
What is being tested?
EXCEL aims to provide community or online exercise programs specifically designed for rural and under-served cancer survivors. The goal is to help participants become life-long exercisers by offering tailored exercise opportunities that they might not otherwise have.
What are the potential side effects?
Since this trial involves group exercise classes, potential side effects may include typical risks associated with physical activity such as muscle soreness, fatigue, and the risk of injury. However, these activities are planned at mild intensity levels suitable for participants' conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I am currently undergoing, about to undergo, or have completed cancer treatment in the last 5 years.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot participate in physical activities.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to one year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Physical Activity Minutes Per Week
Secondary study objectives
Aerobic Endurance
Balance
Barriers and facilitators to exercise participation
+14 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants will be involved in group exercise classes, twice a week for 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Exercise Classes
2014
N/A
~210
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
809 Previous Clinical Trials
884,883 Total Patients Enrolled
University of AlbertaOTHER
940 Previous Clinical Trials
432,543 Total Patients Enrolled
Dalhousie UniversityOTHER
173 Previous Clinical Trials
400,354 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can do light activities without significant difficulty.I have been diagnosed with cancer.I am older than 18 years.I cannot participate in physical activities.I am currently undergoing, about to undergo, or have completed cancer treatment in the last 5 years.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger